Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Citi
Merck
Fish and Richardson
Daiichi Sankyo
Covington
QuintilesIMS
Boehringer Ingelheim
Healthtrust
Chinese Patent Office

Generated: January 19, 2018

DrugPatentWatch Database Preview

CEFDINIR Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for CEFDINIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma CEFDINIR cefdinir CAPSULE;ORAL 065434-001 Jan 7, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma CEFDINIR cefdinir FOR SUSPENSION;ORAL 065473-002 Dec 14, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CEFDINIR cefdinir CAPSULE;ORAL 065330-001 Apr 6, 2007 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CEFDINIR cefdinir FOR SUSPENSION;ORAL 065337-001 Apr 6, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin CEFDINIR cefdinir FOR SUSPENSION;ORAL 065259-001 May 31, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms CEFDINIR cefdinir FOR SUSPENSION;ORAL 065332-001 May 4, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin CEFDINIR cefdinir CAPSULE;ORAL 065264-001 May 19, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Orchid Hlthcare CEFDINIR cefdinir CAPSULE;ORAL 065418-001 Jul 18, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma CEFDINIR cefdinir FOR SUSPENSION;ORAL 065473-001 Dec 14, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms CEFDINIR cefdinir CAPSULE;ORAL 065368-001 May 9, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Argus Health
US Department of Justice
Cipla
Merck
Medtronic
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot